Diclofenamide
From Wikipedia, the free encyclopedia
|
Diclofenamide
|
|
| Systematic (IUPAC) name | |
| 4,5-dichlorobenzene-1,3-disulfonamide | |
| Identifiers | |
| CAS number | |
| ATC code | S01 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C6H6Cl2N2O4S2 |
| Mol. mass | 305.16 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 55% |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Diclofenamide (or dichlorphenamide) is a sulfonamide and a carbonic anhydrase inhibitor.
[edit] References
- Tawil R, McDermott M, Brown R, Shapiro B, Ptacek L, McManis P, Dalakas M, Spector S, Mendell J, Hahn A, Griggs R (2000). "Randomized trials of dichlorphenamide in the periodic paralyses. Working Group on Periodic Paralysis.". Ann Neurol 47 (1): 46–53. PMID 10632100.
- Okada S, Izumi W, Murai M, Komatsu H, Ishimitsu S (1991). "[Diclofenamide Reference Standard (Control 891) of National Institute of Hygienic Sciences]". Eisei Shikenjo Hokoku 109: 148–50. PMID 1364383.
|
||||||||||||||||||||

